These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38396994)

  • 1. ADAM33's Role in Asthma Pathogenesis: An Overview.
    Sleziak J; Gawor A; Błażejewska M; Antosz K; Gomułka K
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADAM metallopeptidase domain 33 (ADAM33): identification and role in airways disease.
    Holgate ST
    Drug News Perspect; 2010; 23(6):381-7. PubMed ID: 20697605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM metallopeptidase domain 33 (ADAM33): a promising target for asthma.
    Tripathi P; Awasthi S; Gao P
    Mediators Inflamm; 2014; 2014():572025. PubMed ID: 24817794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The genetics of asthma: ADAM33 as an example of a susceptibility gene.
    Holgate ST; Yang Y; Haitchi HM; Powell RM; Holloway JW; Yoshisue H; Pang YY; Cakebread J; Davies DE
    Proc Am Thorac Soc; 2006 Jul; 3(5):440-3. PubMed ID: 16799089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of active vitamin D3 on VEGF-induced ADAM33 expression and proliferation in human airway smooth muscle cells: implications for asthma treatment.
    Kim SH; Pei QM; Jiang P; Yang M; Qian XJ; Liu JB
    Respir Res; 2017 Jan; 18(1):7. PubMed ID: 28056993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between ADAM33 gene and asthma in a Chinese population.
    Wang P; Liu QJ; Li JS; Li HC; Wei CH; Guo CH; Gong YQ
    Int J Immunogenet; 2006 Aug; 33(4):303-6. PubMed ID: 16893396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of polymorphisms in ADAM33, a disintegrin and metalloprotease 33, in childhood asthma and lung function in two German populations.
    Schedel M; Depner M; Schoen C; Weiland SK; Vogelberg C; Niggemann B; Lau S; Illig T; Klopp N; Wahn U; von Mutius E; Nickel R; Kabesch M
    Respir Res; 2006 Jun; 7(1):91. PubMed ID: 16784537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing a disintegrin and metalloproteinase‑33 attenuates the proliferation of vascular smooth muscle cells via PI3K/AKT pathway: Implications in the pathogenesis of airway vascular remodeling.
    Yan F; Hao Y; Gong X; Sun H; Ding J; Wang J
    Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33982767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress in study of ADAM33 gene].
    Su ZG; Wen FQ; Feng YL
    Yi Chuan; 2005 Jul; 27(4):636-40. PubMed ID: 16120592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel polymorphisms in the Adam33 gene.
    Chae SC; Yoon KH; Chung HT
    J Hum Genet; 2003; 48(5):278-281. PubMed ID: 12768445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of ADAM33 polymorphisms with childhood asthma in a northern Chinese population.
    Qu S; Sun D; Wang Y; Zhang C; Lv Y; Yao L
    Exp Mol Pathol; 2011 Dec; 91(3):775-9. PubMed ID: 21930123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADAM33 polymorphism: association with bronchial hyper-responsiveness in Korean asthmatics.
    Lee JH; Park HS; Park SW; Jang AS; Uh ST; Rhim T; Park CS; Hong SJ; Holgate ST; Holloway JW; Shin HD
    Clin Exp Allergy; 2004 Jun; 34(6):860-5. PubMed ID: 15196271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a disintegrin and metalloprotease 33 (ADAM33) gene with asthma in ethnically diverse populations.
    Howard TD; Postma DS; Jongepier H; Moore WC; Koppelman GH; Zheng SL; Xu J; Bleecker ER; Meyers DA
    J Allergy Clin Immunol; 2003 Oct; 112(4):717-22. PubMed ID: 14564349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms silence a disintegrin and metalloprotease 33 expression in bronchial epithelial cells.
    Yang Y; Haitchi HM; Cakebread J; Sammut D; Harvey A; Powell RM; Holloway JW; Howarth P; Holgate ST; Davies DE
    J Allergy Clin Immunol; 2008 Jun; 121(6):1393-9, 1399.e1-14. PubMed ID: 18423563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ADAM33 S2 polymorphism is associated with susceptibility to pediatric asthma in the Chinese Han population.
    Fan JG; Wang ZA; Zhao HX
    Genet Test Mol Biomarkers; 2015 Oct; 19(10):573-8. PubMed ID: 26291893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities.
    Holgate ST; Holloway J; Wilson S; Howarth PH; Haitchi HM; Babu S; Davies DE
    J Allergy Clin Immunol; 2006 Mar; 117(3):496-506; quiz 507. PubMed ID: 16522446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction network and pathway studies of ADAM33 potentially relevant to asthma.
    Vishweswaraiah S; Veerappa AM; Mahesh PA; Jayaraju BS; Krishnarao CS; Ramachandra NB
    Ann Allergy Asthma Immunol; 2014 Oct; 113(4):418-24.e1. PubMed ID: 25155083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of a genetic contribution to lung function decline in asthma.
    Koppelman GH; Sayers I
    J Allergy Clin Immunol; 2011 Sep; 128(3):479-84. PubMed ID: 21752436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM33: a newly identified protease involved in airway remodelling.
    Holgate ST; Davies DE; Powell RM; Holloway JW
    Pulm Pharmacol Ther; 2006; 19(1):3-11. PubMed ID: 15953744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM33 expression in asthmatic airways and human embryonic lungs.
    Haitchi HM; Powell RM; Shaw TJ; Howarth PH; Wilson SJ; Wilson DI; Holgate ST; Davies DE
    Am J Respir Crit Care Med; 2005 May; 171(9):958-65. PubMed ID: 15709049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.